Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
新冠肺炎住院治疗后遗留的肺部异常以上皮损伤的生物标志物为特征。
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2026.106134
Stewart Iain, Jacob Joseph, Porter Joanna C, Liu Bin, Tatler Amanda L, Gomez Nancy, Pugh Matthew R, John Alison E, Allen Richard J, Blaikley John F, Chaudhuri Nazia, Denneny Emma, Fabbri Laura, George Peter M, Guillen-Guio Beatriz, Gooptu Bibek, Hall Ian P, Ho Ling Pei, Jarrold Ian, Johnson Simon, Jones Mark G, Khan Fasihul, Mehta Puja, Mitchell Jane, Molyneaux Philip L, Pearl John E, Piper Hanley Karen, Platé Manuela, Quinn Valerie, Rivera-Ortega Pilar, Saunders Laura C, Smith David J F, Spears Mark, Spencer Lisa G, Stanel Stefan C, Thompson A A Roger, Walsh Simon, Wild Jim M, Wootton Dan G, Docherty Annemarie B, Gleeson Fergus, Greenhalf William, Harrison Ewen M, Lone Nazir, Quint Jennifer, Maslova Anastasia, Pohl Moritz, Stephens Adam, Young Simon, Singapuri Amisha, Shikotra Aarti, Sereno Marco, Saunders Ruth M, Richardson Matthew, Raman Betty, Poinasamy Krisnah, McAuley Hamish J C, Marks Michael, Leavy Olivia C, Houchen-Wolloff Linzy, Horsley Alex, Harris Victoria C, Greening Neil, Evans Rachael A, Elneima Omer, Chalmers James D, Brightling Christopher E, Chambers Rachel C, Wain Louise V, Jenkins R Gisli
